Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Science
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Find Cricket Statistics
Hindi
More
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Science
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / World News / Oxford's vaccine, India's best shot against coronavirus, is 70% effective
  • World

    Oxford's vaccine, India's best shot against coronavirus, is 70% effective

    Shalini Ojha
    Written by
    Shalini Ojha
    Twitter
    Last updated on Nov 23, 2020, 08:32 pm
    Oxford's vaccine, India's best shot against coronavirus, is 70% effective
  • The coronavirus vaccine being developed by Oxford University and British pharma giant AstraZeneca is 70% effective, results from large-scale trials have shown, multiple reports said on Monday.

    Though its efficacy doesn't match that of Pfizer and Moderna's, the vaccine by Oxford has an upper hand because it is cheaper.

    India, the second-worst hit nation, has pinned hopes on the vaccine.

    Here's what happened.

  • In this article
    Oxford researchers fought against time to provide relief to world 20,000 volunteers were involved in the trial Two high doses generated 62% protection: Report None of the candidates during trial had to be hospitalized It doesn't require an exhaustive storage infrastructure How does this vaccine work? Efficacy is known, when will the vaccine be available? Common Indian citizens may get doses by April 2021 Poonawalla was happy with the trial results
  • Background

    Oxford researchers fought against time to provide relief to world

    Oxford researchers fought against time to provide relief to world
  • The researchers at the famed university concluded the decades-long process in merely 10 months — a reflection of how desperate the world is to control the pandemic, whose first known case was reported in China in November.

    So far, 1,393,879 have died of the disease and 59,002,157 have been infected.

    That's not it — the economy is in shatters and healthcare systems have collapsed.

  • Trial

    20,000 volunteers were involved in the trial

    20,000 volunteers were involved in the trial
  • The Oxford vaccine, dubbed AZD1222, was seen as the front-runner in the race. To arrive at the "70% efficient" conclusion, the researchers involved over 20,000 volunteers (half in the UK, the rest in Brazil).

    30 cases cropped up where people got infected despite getting inoculated with both the doses.

    101 COVID-19 cases emerged in people who were given a placebo injection.

  • Difference

    Two high doses generated 62% protection: Report

    Two high doses generated 62% protection: Report
  • When participants got two high doses, the protection was 62%; a low dose first and a high one later increased the protection to a staggering 90%, reports BBC.

    Expressing pleasure at the results, Professor Andrew Pollard, the trial's lead investigator, said the data about 90% effectiveness was "intriguing and would mean we would have a lot more doses to distribute."

  • Press note

    None of the candidates during trial had to be hospitalized

    None of the candidates during trial had to be hospitalized
  • In a press release, Oxford informed that none of the candidates who received the doses suffered from severe illness or had to be hospitalized.

    This assumes significance as one volunteer died last month, casting doubts on safety. It was later revealed that the deceased was never given a shot.

    The university added large-scale manufacturing was underway in over 10 countries for "equitable global access."

  • Storage

    It doesn't require an exhaustive storage infrastructure

  • Moreover, the vaccine can be easily stored at a refrigerator temperature, said Oxford University, adding that existing healthcare systems won't have to be tweaked for it.

    On the findings, Professor Sarah Gilbert, Professor of Vaccinology, said, "The announcement today takes us another step closer to the time when we can use vaccines to bring an end to the devastation caused by SARS-CoV-2."

  • Working

    How does this vaccine work?

  • Notably, the vaccine has been made from a weakened version of a common cold virus, or adenovirus, that causes infections in chimpanzees and has been genetically modified to not grow in humans.

    It contains the gene that makes the spike protein of the novel coronavirus and mimics a COVID-19 infection to prime the body to generate neutralizing antibodies to fight off the actual virus.

  • Availability

    Efficacy is known, when will the vaccine be available?

  • With results of vaccine candidates coming in, a question about when common people will get injected has been looming large.

    BioNTech, the German company developing the vaccine with US-based Pfizer, said last week, its doses will be out before Christmas. Following Pfizer, Moderna's vaccine will be available.

    Similarly, Oxford's vaccine will be released after approvals from regulators. This process could consume a few weeks.

  • India

    Common Indian citizens may get doses by April 2021

  • India has high expectations from Oxford's vaccine, called Covishield in the country. The world's largest vaccine manufacturer, Serum Institute of India (SII), has joined hands with Oxford-AstraZeneca for mass production.

    SII CEO Adar Poonawalla said last week that the company will seek approval for giving the vaccine to high-risk individuals by December.

    Common citizens will get the doses by April 2021, he claimed.

  • Quote

    Poonawalla was happy with the trial results

  • Evidently elated, Poonwalla tweeted, "I am delighted to hear that, Covishield, a low-cost, logistically manageable & soon to be widely available, #COVID19 vaccine, will offer protection up to 90% in one type of dosage regime and 62% in the other dosage regime. (sic)"

  • Pfizer
  • BBC
  • Oxford
  • Oxford University
  • Coronavirus
  •  
Latest News
  • NewsBytes Briefing: Apple M1 Macs are dying slowly, and more
    NewsBytes Briefing: Apple M1 Macs are dying slowly, and more
    Science
  • Barack Obama, Bruce Springsteen team up with Spotify for podcast
    Barack Obama, Bruce Springsteen team up with Spotify for podcast
    Entertainment
  • Mi 11 Lite appears in live images, features detailed
    Mi 11 Lite appears in live images, features detailed
    Science
  • Nissan Magnite garners 40,000 bookings in India; production ramped up
    Nissan Magnite garners 40,000 bookings in India; production ramped up
    Auto
  • Netizens decode message hidden in NASA's Perseverance rover's parachute
    Netizens decode message hidden in NASA's Perseverance rover's parachute
    Science
Related Timelines
  • After Pfizer, Oxford-AstraZeneca's COVID-19 vaccine approved in UK
    After Pfizer, Oxford-AstraZeneca's COVID-19 vaccine approved in UK
    World
  • Can prepare vaccine against mutated virus in 6 weeks: BioNTech
    Can prepare vaccine against mutated virus in 6 weeks: BioNTech
    Science
  • Getting vaccinated for COVID-19 is voluntary, says Centre
    Getting vaccinated for COVID-19 is voluntary, says Centre
    India
  • Manufacturing error in Oxford-AstraZeneca coronavirus vaccine raises pertinent questions
    Manufacturing error in Oxford-AstraZeneca coronavirus vaccine raises pertinent questions
    Science
Trending Topics
Coronavirus
Next News Article
Share
Cancel

Want to share it with your friends too?

Facebook Whatsapp Twitter Linkedin
Copied

Love World news?

Subscribe to stay updated.

World Thumbnail
India News Business News World News Politics News Sports News Science News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Bharti Airtel Mukesh Ambani Indian Premier League Samsung Virat Kohli Rohit Sharma
Cricket News Facebook YouTube Hollywood News WhatsApp Netflix Bollywood News ISRO Spotify Yoga
Honda Batman Football News BMW Vaccine Reliance Jio OPPO Food News, Healthy Recipes Royal Challengers Bangalore Toyota
Fashion Tips Ishant Sharma Farmers Protest Mercedes Isha Ambani India Vs England Cricket OnePlus Mobiles Android TV Smart TV Robert Lewandowski
Marvel Comics Avengers Neha Kakkar Mena Massoud
About Us Privacy Policy Terms & Conditions Contact Us News News Archive Topics Archive Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2021